{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:07:49Z","timestamp":1751688469971,"version":"3.41.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbr.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T16:43:00Z","timestamp":1525797780000},"page":"44-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Differential behavioral and glial responses induced by dopaminergic mechanisms in the iNOS knockout mice"],"prefix":"10.1016","volume":"350","author":[{"given":"Ana Carolina","family":"Issy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glauce Crivelaro","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Henrique Dias de","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrine S.","family":"Trist\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Del-Bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariza","family":"Bortolanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-6147(91)90526-X","article-title":"Nitric oxide as a neuronal messenger","volume":"12","author":"Snyder","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.002_bib0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuint.2006.04.007","article-title":"Signals for the induction of nitric oxide synthase in astrocytes","volume":"49","author":"Saha","year":"2006","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.002_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N","article-title":"Production of nitric oxide by glial cells: regulation and potential roles in the CNS","volume":"29","author":"Murphy","year":"2000","journal-title":"Glia"},{"issue":"3\u20134","key":"10.1016\/j.bbr.2018.05.002_bib0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ceca.2004.02.011","article-title":"Role of nitric oxide after brain ischaemia","volume":"36","author":"Moro","year":"2004","journal-title":"Cell. Calcium"},{"issue":"2","key":"10.1016\/j.bbr.2018.05.002_bib0025","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1471-4159.2000.740785.x","article-title":"Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex","volume":"74","author":"Olivenza","year":"2000","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1073858410366481","article-title":"Nitric oxide signaling in brain function, dysfunction, and dementia","volume":"16","author":"Steinert","year":"2010","journal-title":"Neuroscientist"},{"issue":"6","key":"10.1016\/j.bbr.2018.05.002_bib0035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0361-9230(00)00282-3","article-title":"Role of nitric oxide in the regulation of monoaminergic neurotransmission","volume":"52","author":"Kiss","year":"2000","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuint.2003.11.004","article-title":"Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors","volume":"45","author":"Kiss","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2018.05.002_bib0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fphys.2012.00372","article-title":"Investigations into potential extrasynaptic communication between the dopaminergic and nitrergic systems","volume":"3","author":"Mitkovski","year":"2012","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.bbr.2018.05.002_bib0050","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1176\/appi.ajp.157.11.1738","article-title":"Novel neurotransmitters and their neuropsychiatric relevance","volume":"157","author":"Snyder","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2018.05.002_bib0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12640-015-9562-8","article-title":"Signaling mechanisms in the nitric oxide donor- and amphetamine-induced dopamine release in mesencephalic primary cultured neurons","volume":"29","author":"Salum","year":"2016","journal-title":"Neurotox. Res."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00213-009-1687-0","article-title":"Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity","volume":"207","author":"Hoque","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.bbr.2018.05.002_bib0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10571-005-3065-8","article-title":"Role of nitric oxide on motor behavior","volume":"25","author":"Del Bel","year":"2005","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.002_bib0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/138161211795164176","article-title":"Role of nitric oxide in motor control: implications for Parkinson\u2019s disease pathophysiology and treatment","volume":"17","author":"Del-Bel","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.002_bib0075","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1006\/niox.2000.0288","article-title":"Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson\u2019s disease","volume":"4","author":"Gatto","year":"2000","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.bbr.2018.05.002_bib0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00001756-199512000-00038","article-title":"L-NOARG, an inhibitor of nitric oxide synthase, induces catalepsy in mice","volume":"7","author":"Marras","year":"1995","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s002130050003","article-title":"Sub-chronic inhibition of nitric-oxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice","volume":"147","author":"Del Bel","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.bbr.2018.05.002_bib0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00213-007-0834-8","article-title":"Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice","volume":"194","author":"Echeverry","year":"2007","journal-title":"Psychopharmacology (Berl)."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.002_bib0095","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0022-3565(24)36836-3","article-title":"Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase","volume":"282","author":"Itzhak","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1672","key":"10.1016\/j.bbr.2018.05.002_bib0100","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0190","article-title":"Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson\u2019s disease induced by L-DOPA?","volume":"370","author":"Bortolanza","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.002_bib0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/hmg\/ddg009","article-title":"Association between Parkinson\u2019s disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study","volume":"12","author":"Levecque","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.002_bib0110","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","article-title":"Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo","volume":"74","author":"Dehmer","year":"2000","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.002_bib0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.freeradbiomed.2010.12.026","article-title":"Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease","volume":"50","author":"Broom","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbr.2018.05.002_bib0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.brainres.2008.01.088","article-title":"A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway","volume":"1203","author":"Gomes","year":"2008","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.bbr.2018.05.002_bib0125","doi-asserted-by":"crossref","first-page":"e843","DOI":"10.1371\/journal.pone.0000843","article-title":"Enhanced astrocytic nitric oxide production and neuronal modifications in the neocortex of a NOS2 mutant mouse","volume":"2","author":"Buskila","year":"2007","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbr.2018.05.002_bib0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(98)00825-5","article-title":"The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors","volume":"364","author":"Andringa","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/1098-1136(20010315)33:4<324::AID-GLIA1031>3.0.CO;2-M","article-title":"Repression of proinflammatory cytokine and inducible nitric oxide synthase (NOS2) gene expression in activated microglia by N-acetyl-O-methyldopamine: protein kinase A-dependent mechanism","volume":"33","author":"Cho","year":"2001","journal-title":"Glia"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2018.05.002_bib0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-5728(02)00260-6","article-title":"Characterization of neurotransmitters and dopamine attenuation of inducible nitric oxide synthase in glioma cells","volume":"131","author":"Mazzio","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbr.2018.05.002_bib0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbr.2016.04.043","article-title":"Effects of the inducible nitric oxide synthase inhibitor aminoguanidine in two different rat models of schizophrenia","volume":"309","author":"Lafioniatis","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"16","key":"10.1016\/j.bbr.2018.05.002_bib0150","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/glia.21068","article-title":"Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy","volume":"58","author":"Mishra","year":"2010","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/157015912804499465","article-title":"Neuronal-glial interactions define the role of nitric oxide in neural functional processes","volume":"10","author":"Contestabile","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbr.2018.05.002_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-40764-7_1","article-title":"Glial cells and integrity of the nervous system","volume":"949","author":"von Bernhardi","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.bbr.2018.05.002_bib0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejpain.2005.07.004","article-title":"Antinociceptive activity of the selective iNOS inhibitor AR-C102222 in rodent models of inflammatory, neuropathic and post-operative pain","volume":"10","author":"LaBuda","year":"2006","journal-title":"Eur. J. Pain"},{"issue":"34","key":"10.1016\/j.bbr.2018.05.002_bib0170","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1523\/JNEUROSCI.2128-08.2008","article-title":"cGMP produced by NO-sensitive guanylyl cyclase essentially contributes to inflammatory and neuropathic pain by using targets different from cGMP-dependent protein kinase I","volume":"28","author":"Schmidtko","year":"2008","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2018.05.002_bib0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pain.2005.10.028","article-title":"GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain","volume":"120","author":"De Alba","year":"2006","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.bbr.2018.05.002_bib0180","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/jpet.110.167585","article-title":"The role of nitric oxide in the local antiallodynic and antihyperalgesic effects and expression of delta-opioid and cannabinoid-2 receptors during neuropathic pain in mice","volume":"334","author":"Hervera","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2018.05.002_bib0185","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1744-8069-7-50","article-title":"Reduced spinal microglial activation and neuropathic pain after nerve injury in mice lacking all three nitric oxide synthases","volume":"7","author":"Kuboyama","year":"2011","journal-title":"Mol. Pain"},{"issue":"8","key":"10.1016\/j.bbr.2018.05.002_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043693","article-title":"Carbon monoxide reduces neuropathic pain and spinal microglial activation by inhibiting nitric oxide synthesis in mice","volume":"7","author":"Hervera","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bbr.2018.05.002_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014321","article-title":"The spinal cord expression of neuronal and inducible nitric oxide synthases and their contribution in the maintenance of neuropathic pain in mice","volume":"5","author":"Hervera","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbr.2018.05.002_bib0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuropharm.2011.09.004","article-title":"Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence","volume":"62","author":"Montezuma","year":"2012","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.bbr.2018.05.002_bib0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/cns.12708","article-title":"Antidepressant-like effects of tetrahydroxystilbene glucoside in mice: involvement of BDNF signaling cascade in the hippocampus","volume":"23","author":"Wang","year":"2017","journal-title":"CNS Neurosci. Ther."},{"issue":"8","key":"10.1016\/j.bbr.2018.05.002_bib0210","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1017\/S1461145709000236","article-title":"Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression","volume":"12","author":"Berrocoso","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.002_bib0215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00213-002-1009-2","article-title":"Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice","volume":"161","author":"Del Bel","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.bbr.2018.05.002_bib0220","first-page":"205","article-title":"Alpha-synuclein A30P point-mutation generates age-dependent nigrostriatal deficiency in mice","volume":"59","author":"Plaas","year":"2008","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbr.2018.05.002_bib0225","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbr.2016.06.014","article-title":"Agmatine attenuates reserpine-induced oral dyskinesia in mice: role of oxidative stress, nitric oxide and glutamate NMDA receptors","volume":"312","author":"Cunha","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.002_bib0230","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1046\/j.1460-9568.2003.02525.x","article-title":"Topography of cocaine-induced gene regulation in the rat striatum: relationship to cortical inputs and role of behavioural context","volume":"17","author":"Willuhn","year":"2003","journal-title":"Eur J. Neurosci."},{"key":"10.1016\/j.bbr.2018.05.002_bib0235","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19103","article-title":"A comprehensive excitatory input map of the striatum reveals novel functional organization","volume":"5","author":"Hunnicutt","year":"2016","journal-title":"Elife"},{"issue":"8","key":"10.1016\/j.bbr.2018.05.002_bib0240","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nn.4332","article-title":"The mouse cortico-striatal projectome","volume":"19","author":"Hintiryan","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"54","key":"10.1016\/j.bbr.2018.05.002_bib0245","doi-asserted-by":"crossref","first-page":"92578","DOI":"10.18632\/oncotarget.21502","article-title":"Early antagonism of cerebral high mobility group box-1 protein is benefit for sepsis induced brain injury","volume":"8","author":"Ren","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbr.2018.05.002_bib0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1742-2094-9-71","article-title":"Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice","volume":"9","author":"Diz-Chaves","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"May (1\u20133)","key":"10.1016\/j.bbr.2018.05.002_bib0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","article-title":"Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol","volume":"164","author":"Gomes","year":"2015","journal-title":"Schizophr. Res."},{"issue":"August","key":"10.1016\/j.bbr.2018.05.002_bib0260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2014.05.004","article-title":"The role of gaseous neurotransmitters in the antinociceptive effects of morphine during acute thermal pain","volume":"737","author":"Gou","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0265","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neures.2013.02.002","article-title":"Effects of lamotrigine on behavior, oxidative parameters and signaling cascades in rats exposed to the chronic mild stress model","volume":"75","author":"Abelaira","year":"2013","journal-title":"Neurosci. Res."},{"issue":"9","key":"10.1016\/j.bbr.2018.05.002_bib0270","doi-asserted-by":"crossref","first-page":"e843","DOI":"10.1371\/journal.pone.0000843","article-title":"Enhanced astrocytic nitric oxide production and neuronal modifications in the neocortex of a NOS2 mutant mouse","volume":"2","author":"Buskila","year":"2007","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbr.2018.05.002_bib0275","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv005","article-title":"Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system","volume":"18","author":"Lisboa","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"15","key":"10.1016\/j.bbr.2018.05.002_bib0280","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/glia.21057","article-title":"Physiologic role for \u201cinducible\u201d nitric oxide synthase: a new form of astrocytic-neuronal interface","volume":"58","author":"Amitai","year":"2010","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.bbr.2018.05.002_bib0285","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/0735-7044.102.5.748","article-title":"The catalepsy test: its ups and downs","volume":"102","author":"Sanberg","year":"1988","journal-title":"Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.002_bib0290","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3565(25)12023-5","article-title":"Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity","volume":"275","author":"Seeger","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.002_bib0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1988.01800250087012","article-title":"Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs","volume":"45","author":"Farde","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0300","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0305","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s002130000466","article-title":"Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats","volume":"150","author":"Wadenberg","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"issue":"5","key":"10.1016\/j.bbr.2018.05.002_bib0310","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/0735-7044.102.5.748","article-title":"The catalepsy test: its ups and downs","volume":"102","author":"Sanberg","year":"1988","journal-title":"Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0315","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0320","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s002130000466","article-title":"Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats","volume":"150","author":"Wadenberg","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.bbr.2018.05.002_bib0325","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s002130051146","article-title":"Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP","volume":"147","author":"Shiozaki","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2018.05.002_bib0330","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbr.2013.06.031","article-title":"Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine","volume":"253","author":"Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.05.002_bib0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainresbull.2018.01.017","article-title":"Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine","volume":"139","author":"Lins","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbr.2018.05.002_bib0340","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"11","key":"10.1016\/j.bbr.2018.05.002_bib0345","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1177\/0269881116661075","article-title":"Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next","volume":"30","author":"Swerdlow","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2018.05.002_bib0350","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fneur.2014.00049","article-title":"Maladaptive plasticity in levodopa-induced dyskinesias and tardive dyskinesias: old and new insights on the effects of dopamine receptor pharmacology","volume":"5","author":"Cerasa","year":"2014","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.002_bib0355","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/bpa.12253","article-title":"Molecular, neurochemical, and behavioral hallmarks of reserpine as a model for parkinson's disease: new perspectives to a long-standing model","volume":"25","author":"Le\u00e3o","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbr.2018.05.002_bib0360","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pbb.2013.01.001","article-title":"Gallic acid decreases vacuous chewing movements induced by reserpine in rats","volume":"104","author":"Reckziegel","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.bbr.2018.05.002_bib0365","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.neuropharm.2005.01.014","article-title":"Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity","volume":"48","author":"Faria","year":"2005","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.bbr.2018.05.002_bib0370","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv005","article-title":"Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system","volume":"18","author":"Lisboa","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2018.05.002_bib0375","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12031-012-9814-5","article-title":"Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson\u2019s disease","volume":"48","author":"Li","year":"2012","journal-title":"J. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.bbr.2018.05.002_bib0380","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/mcne.2000.0914","article-title":"Inflammatory regulators in parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and-2","volume":"16","author":"Knott","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.002_bib0385","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2018.05.002_bib0390","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fncel.2015.00322","article-title":"Implications of glial nitric oxide in neurodegenerative diseases","volume":"9","author":"Yuste","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"12","key":"10.1016\/j.bbr.2018.05.002_bib0395","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/syn.21941","article-title":"l-DOPA-induced dyskinesia in Parkinson\u2019s disease: are neuroinflammation and astrocytes key elements?","volume":"70","author":"Del-Bel","year":"2016","journal-title":"Synapse"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818300305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818300305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T10:54:43Z","timestamp":1751626483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432818300305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":79,"alternative-id":["S0166432818300305"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2018.05.002","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential behavioral and glial responses induced by dopaminergic mechanisms in the iNOS knockout mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}